Background
==========

Epidemiological data can be useful in the design of new prevention strategies, especially in primary health care \[[@B1]\]. There are worldwide data available regarding the prevalence, morbidity and mortality of chronic diseases. Data from the World Health Organization (WHO) indicate that the most important causes of death are currently ischemic heart disease and cerebrovascular disease \[[@B2]\].

The development of electronic health records, especially in primary care, may help in the identification of the burden of several diseases in each region. The use of such records may be of great importance for health systems, considering that the North Shore Hospital System in Long Island, New York, announced recently that it will pay an incentive of up to \$40,000 to each physician in its network who adopts its electronic health record, paying 50% of the cost to physicians who install an electronic health record that communicates with the hospital and 85% of the cost if the physician also shares de-identified data on the quality of care \[[@B3]\].

On the other hand, the International Classification of Primary Care (ICPC) recently celebrated its 21 years. This coding system is very easy and very useful in primary health care \[[@B4]-[@B6]\]. In a recent epidemiological study conducted in Spain, ICPC was used in conjunction with electronic health records, for the estimation of the prevalence of major diseases in the general population \[[@B7]\].

In Greece, the national health system is designed in three levels. Primary health care centres compose the first level which represents the primary health care system. General practitioners are the key component of the primary health care centres. Thus, their role is very important as general practitioners represent the link between public and the national health system. However, the establishment of an integrated primary health care system in Greece is still under development \[[@B8]\].

However, in Greece there is lack of a recording system in primary health care, rendering the design of large epidemiological studies difficult and complex. The aim of this study is to estimate the prevalence and morbidity of ten major chronic diseases in primary health care centres serving a semirural population sample in Thessaly, central Greece. Differences in morbidity between genders as well as between young and elderly were further evaluated.

Methods
=======

Study design
------------

Data collection was performed from January to December 2008. Thessaly is a district in central Greece with four prefectures and seventeen primary health care centres with a total population of 740,115 residents \[[@B9]\] that represents approximately 8% of the total population of Greece. All these primary health care centres are part of the national health system and correspond mainly to rural and semirural population. Four primary health centres were randomly selected to be recorded, one from each prefecture. The primary health care centres selected correspond to a population of 126,843 residents (data derived from local authorities). The study group visited one centre per week in order to visit all selected centres in one month. The centre visited in each of the four weeks of each month was chosen in a random order. Overall, twelve visits were performed in each centre.

Study participants were all subjects over 14 years old who visited primary health care centres for any reason and were willing to participate in the study. A structured questionnaire was completed by the study coordinators upon the arrival of each subject. The study questionnaire included questions about demographics, medical history and current medication for chronic diseases. The study coordinators additionally checked the medical records of each patient, in order to record all chronic diseases in detail.

The chronic diseases of each subject were identified and coded using the ICPC system \[[@B4]\]. Each disease recorded was included in the respective organic system according to ICPC codes (Table [1](#T1){ref-type="table"}). The ten most common and burdensome chronic diseases, based on the main causes of death and disease burden in the United States and the most common diagnoses in primary care, were recorded separately \[[@B10]\]. The study was approved by the Ethics committee of the University Hospital of Larissa and all subjects provided informed consent.

###### 

ICPC codes for selected diseases and organic systems

  A. General                                
  ----------------------------------------- -------------------------
  B. Blood, lymphatics                      
                                            
  C. Digestive                              
                                            
  F. Eye                                    
                                            
  H. Ear                                    
                                            
  K. Circulatory                            
                                            
   Elevated blood pressure                  K85, K86, K87
                                            
   Coronary heart disease                   K74, K75
                                            
  L. Musculoskeletal                        
                                            
   Osteoarthritis                           L83, L84, L89, L90, L91
                                            
   Osteoporosis                             L95
                                            
  N. Neurological                           
                                            
  P. Psychological                          
                                            
   Depression                               P03, P76, P78
                                            
   Anxiety disorders                        P01, P74, P75, P79, P82
                                            
  R. Respiratory                            
                                            
   Asthma                                   R96
                                            
   COPD                                     R79, R95
                                            
  T. Endocrine, metabolic and nutritional   
                                            
   Lipid disorder                           T93
                                            
   Diabetes                                 T89, T90
                                            
  U. Urology                                
                                            
  X. Genital Female                         
                                            
  Y. Genital male                           

Statistical analysis
--------------------

Demographic data are presented as median (interquartile range) whereas categorical variables are presented as percentages. Normality of data was estimated with the use of D\'Agostino-Pearson normality test. Comparison between medians was performed using Mann-Whitney U test for skewed data. The prevalence was estimated taking into account the cluster design and based on the cluster sample total \[[@B11],[@B12]\]. The analysis was performed using the proc survey means of SAS v.90 and GraphPad Prism v.5.0. The prevalence of each disease is presented per 10,000 of population.

Results
=======

Demographic data are presented in Table [2](#T2){ref-type="table"}. In total, 20,299 subjects were willing to participate in the study (56.4% female). Participants were distributed according to the gender and age group (\< 65 years, ≥65 years). According to Table [2](#T2){ref-type="table"}, the majority of participants were elderly women. In the age group \< 65 years, males were younger than females (48 vs. 51 years old), whereas in the age group ≥65 years old males were older than females (74 vs. 73 years old).

###### 

Demographic data of the study participants

                   Male              Female          Total                                                             
  ---------------- ----------------- --------------- --------------- ----------------- --------------- --------------- ------------
                   **\< 65 years**   **≥65 years**   **Total**       **\< 65 years**   **≥65 years**   **Total**       
                                                                                                                       
  N                3703              5155            8858            4720              6721            11441           20299
                                                                                                                       
  Age              48 (35-58)\*      74 (70-79)\^    68 (52-75)      51 (36-60)\*      73 (69-78)\^    68 (55-74)      68 (54-75)
                                                                                                                       
  Disease number                                                                                                       
                                                                                                                       
   0               9 (0.24%)         5 (0.10%)       14 (0.16%)      32 (0.68%)        4 (0.06%)       36 (0.31%)      50
                                                                                                                       
   1               3341 (90.22%)     3732 (72.40%)   7073 (79.85%)   4001 (84.77%)     4522 (67.28%)   8523 (74.50%)   15596
                                                                                                                       
   2               288 (7.78%)       1087 (21.09%)   1375 (15.52%)   544 (11.52%)      1581 (23.53%)   2125 (18.57%)   3500
                                                                                                                       
   3               62 (1.67%)        273 (5.30%)     335 (3.78%)     128 (2.71%)       512 (7.62%)     640 (5.59%)     975
                                                                                                                       
   4               3 (0.09%)         54 (1.05%)      57 (0.64%)      14 (0.30%)        91 (1.35%)      105 (0.92%)     162
                                                                                                                       
   5               0 (0%)            4 (0.06%)       4 (0.05%)       1 (0.02%)         10 (0.15%)      11 (0.1%)       15
                                                                                                                       
   6               0 (0%)            0 (0%)          0 (0%)          0 (0%)            1 (0.01%)       1 (0.01%)       1

\*,\^ P \< 0.0001

Table [2](#T2){ref-type="table"} and Figure [1](#F1){ref-type="fig"} present the distribution of participants according to their number of diseases. In all age groups the majority of participants suffered from a single disease, however with several variations. For example, a significant proportion of people ≥65 years old had two or more diseases. Moreover, women had more commonly 2 or more diseases in both age groups.

![**Distribution of disease numbers between genders and age groups**.](1472-6963-10-252-1){#F1}

The estimated prevalence of each system or disease, expressed per 10000 people, is shown in Table [3](#T3){ref-type="table"}. The most prevalent diseases overall were circulatory disorders, including arterial hypertension and coronary heart disease. Other diseases with high prevalence were endocrine, metabolic (especially lipid disorders), musculoskeletal and respiratory diseases. Interestingly, osteoarthritis and asthma, two chronic diseases classified in the two latter organic systems, presented low prevalence. It should be mentioned also that the prevalence of chronic obstructive pulmonary disease (COPD) was considerably low compared to other diseases.

###### 

Estimated prevalence of the recorded diseases

  ---------------------------------------------------------------------------------------------
                                            N      Estimated prevalence\    95% CI
                                                   (per 10,000 residents)   
  ----------------------------------------- ------ ------------------------ -------------------
  A. General                                1099   552.0                    (471.0 - 633.0)

                                                                            

  B. Blood, lymphatics                      486    240.6                    (175.0 - 306.2)

                                                                            

  C. Digestive                              1688   844.6                    (673.2 - 1016.1)

                                                                            

  F. Eye                                    451    222.8                    (167.1 - 278.6)

                                                                            

  H. Ear                                    207    104.8                    (45.5 - 164.1)

                                                                            

  K. Circulatory                            7026   3409.2                   (2959.4 - 3860.3)

                                                                            

   Elevated blood pressure                  3719   1813.2                   (1505.2 - 2121.1)

                                                                            

   Coronary heart disease                   2321   1107.2                   (710.2 - 1504.2)

                                                                            

  L. Musculoskeletal                        3150   1551.4                   (1448.1 - 1654.7)

                                                                            

   Osteoarthritis                           684    340.0                    (249.6 - 430.4)

                                                                            

   Osteoporosis                             1047   500.7                    (403.3 - 598.0)

                                                                            

  N. Neurological                           975    489.0                    (420.4 - 557.6)

                                                                            

  P. Psychological                          1968   949.9                    (669.8 - 1230.0)

                                                                            

   Depression                               580    269.1                    (79.9 - 458.2)

                                                                            

   Anxiety disorders                        376    191.4                    (132.4 - 250.4)

                                                                            

  R. Respiratory                            3122   1548.3                   (1353.7 - 1742.9)

                                                                            

   Asthma                                   103    53.8                     (34.2 - 73.4)

                                                                            

   COPD                                     706    349.6                    (277.7 - 421.6)

                                                                            

  S. Skin                                   927    452.7                    (381.9 - 523.6)

                                                                            

  T. Endocrine, metabolic and nutritional   4058   1945.1                   (1641.7 - 2248.5)

                                                                            

   Lipid disorder                           2026   960.4                    (741.4 - 1179.4)

                                                                            

   Diabetes                                 1472   714.6                    (646.9 - 782.4)

                                                                            

  U. Urology                                545    268.8                    (193.6 - 344.0)

                                                                            

  X. Genital Female                         242    120.7                    (99.4 - 142.1)

                                                                            

  Y. Genital male                           302    147.5                    (114.7 - 180.3)
  ---------------------------------------------------------------------------------------------

CI: confidence intervals

Differences between genders
---------------------------

The comparison of the estimated prevalence of the diseases revealed significant differences between the two genders, as presented in Table [4](#T4){ref-type="table"}. The most prominent difference is the higher prevalence of the diseases of musculoskeletal system in women, being more than 10-fold higher for osteoporosis. Another important difference is the fact that psychological diseases, especially depression, were more prevalent in females. Circulatory diseases were slightly more prevalent in females, with the exception of coronary heart disease which was slightly more common in males. Another interesting finding is the higher prevalence of COPD compared to asthma in females.

###### 

Estimated prevalence for each disease according to gender and age group

                                          Male              Female                     Total                                                                                                                                                                                      
  --------------------------------------- ----------------- -------------------------- ----------- -------------------------- --------------- -------------------------- ------- -------------------------- ------- -------------------------- ------- -------------------------- ------
                                          **\< 65 years**   **≥65 years**              **Total**   **\< 65 years**            **≥65 years**   **Total**                                                                                                                           
                                                                                                                                                                                                                                                                                  
                                          **N**             **Prevalence (95% CI)**    **N**       **Prevalence (95% CI)**    **N**           **Prevalence (95% CI)**    **N**   **Prevalence (95% CI)**    **N**   **Prevalence (95% CI)**    **N**   **Prevalence (95% CI)**    
                                                                                                                                                                                                                                                                                  
  A.General                               460               1262.5 (1107.5 - 1417.5)   183         358.2 (250.5 - 465.9)      643             738.0 (617.1 - 859.0)      278     591.8 (522.2 - 661.5)      178     275.4 (214.6 - 336.2)      456     407.0 (353.9 - 460.0)      1099
                                                                                                                                                                                                                                                                                  
  B.Blood, lymphatics                     31                85.8 (60.4 - 111.1)        119         246.7 (143.2 - 350.3)      150             173.1 (133.0 - 213.3)      124     256.4 (172.9 - 339.8)      212     322.2 (214.9 - 429.5)      336     292.9 (199.8 - 386.0)      486
                                                                                                                                                                                                                                                                                  
  C.Digestive                             341               937.8 (804.4 - 1071.2)     431         822.9 (585.0 - 1060.7)     772             876.7 (701.1 - 1052.3)     398     859.1 (707.3 - 1010.8)     518     788.5 (582.0 - 995.0)      916     820.4 (642.7 - 998.2)      1688
                                                                                                                                                                                                                                                                                  
  F.Eye                                   89                238.8 (157.3 - 320.3)      117         231.1 (178.2 - 284.0)      206             233.1 (173.5 - 292.7)      56      119.0 (114.8 - 123.1)      189     282.0 (188.8 - 375.3)      245     215.2 (155.1 - 275.3)      451
                                                                                                                                                                                                                                                                                  
  H.Ear                                   58                155.5 (90.2 - 220.7)       31          66.6 (23.9 - 109.4)        89              105.0 (50.9 - 159.1)       78      158.4 (56.9 - 260.0)       40      61.9 (12.8 - 111.0)        118     104.7 (31.3 - 178.2)       207
                                                                                                                                                                                                                                                                                  
  K.Circulatory                           715               1940.0 (1730.1 - 2149.9)   2445        4700.9 (4485.4 - 4916.4)   3160            3532.6 (3186.1 - 3879.1)   890     1892.2 (1494.8 - 2289.6)   2976    4344.2 (3959.3 - 4729.2)   3866    3311.7 (2775.2 - 3848.1)   7026
                                                                                                                                                                                                                                                                                  
   Elevated blood pressure                389               1062.6 (868.6 - 1256.5)    1096        2105.5 (1743.4 - 2467.5)   1485            1665.3 (1362.0 - 1968.5)   589     1251.2 (1006.4 - 1496.0)   1645    2422.7 (2087.1 - 2758.2)   2234    1926.8 (1595.3 - 2258.4)   3719
                                                                                                                                                                                                                                                                                  
   Coronary heart disease                 225               608.7 (369.6 - 847.7)      959         1817.3 (1351.9 - 2282.6)   1184            1308.9 (890.7 - 1727.2)    179     380.8 (148.0 - 613.6)      958     1354.4 (946.4 - 1762.5)    1137    949.3 (562.4 - 1336.2)     2321
                                                                                                                                                                                                                                                                                  
  L.Musculoskeletal                       416               1122.3 (1047.1 - 1197.5)   457         886.9 (826.0 - 947.8)      873             988.0 (926.4 - 1049.6)     795     1696.8 (1491.5 - 1902.0)   1482    2216.7 (2017.8 - 2415.6)   2277    1990.4 (1795.6 - 2185.3)   3150
                                                                                                                                                                                                                                                                                  
   Osteoarthritis                         60                163.3 (131.8 - 194.7)      121         234.5 (171.9 - 297.0)      181             203.1 (158.4 - 247.7)      145     315.4 (238.3 - 392.5)      358     537.7 (366.9 - 708.5)      503     447.2 (316.8 - 577.6)      684
                                                                                                                                                                                                                                                                                  
   Osteoporosis                           11                27.6 (0 - 55.7)            37          68.8 (36.3 - 101.3)        48              51.0 (20.3 - 81.7)         300     629.3 (499.4 - 759.3)      699     1014.4 (911.7 - 1117.1)    999     850.3 (712.8 - 987.8)      1047
                                                                                                                                                                                                                                                                                  
  N.Neurological                          122               328.9 (284.5 - 373.2)      278         545.2 (426.0 - 664.5)      400             456.1 (393.7 - 518.6)      216     466.6 (391.3 - 542.0)      359     550.6 (462.5 - 638.7)      575     515.4 (434.5 - 596.4)      975
                                                                                                                                                                                                                                                                                  
  P.Phychological                         321               873.9 (696.7 - 1051.1)     396         733.3 (472.5 - 994.1)      717             792.3 (571.6 - 1031.1)     498     1074.1 (726.5 - 1241.7)    753     1078.6 (758.1 - 1399.0)    1251    1075.5 (752.5 - 1398.5)    1968
                                                                                                                                                                                                                                                                                  
   Depression                             42                111.3 (21.4 - 201.3)       115         201.2 (39.9 - 362.6)       157             165.0 (30.3 - 299.7)       141     305.2 (104.7 - 505.7)      282     379.4 (129.9 - 628.9)      423     349.9 (117.5 - 582.2)      580
                                                                                                                                                                                                                                                                                  
   Anxiety disorders                      77                212.1 (125.1 - 299.0)      68          128.5 (77.6 - 179.3)       145             168.5 (120.5 - 216.5)      115     248.5 (162.9 - 334.2)      116     179.7 (102.9 - 256.5)      231     209.1 (137.1 - 281.2)      376
                                                                                                                                                                                                                                                                                  
  R.Respiratory                           717               1887.6 (1529.3 - 2245.9)   780         1548.0 (1316.7 - 1779.4)   1497            1692.3 (1503.0 - 1881.7)   937     1969.7 (1646.7 - 2292.6)   688     1029.0 (996.3 - 1061.6)    1625    1436.4 (1234.6 - 1638.3)   3122
                                                                                                                                                                                                                                                                                  
   Asthma                                 15                40.6 (20.5 - 60.8)         14          29.6 (4.0 - 55.2)          29              33.9 (16.2 - 51.7)         40      87.4 (58.7 - 116.1)        34      57.4 (23.9 - 90.9)         74      69.4 (41.1 - 97.6)         103
                                                                                                                                                                                                                                                                                  
   COPD                                   71                188.3 (144.1 - 232.5)      326         640.6 (545.9 - 735.4)      397             451.9 (392.7 - 511.0)      79      172.7 (120.8 - 224.7)      230     332.3 (212.0 - 452.5)      309     269.4 (184.3 - 354.5)      706
                                                                                                                                                                                                                                                                                  
  S.Skin                                  286               779.3 (671.5 - 887.2)      158         294.2 (208.2 - 380.2)      444             497.1 (429.4 - 564.7)      290     612.7 (526.7 - 698.7)      193     273.2 (178.5 - 367.8)      483     418.0 (330.2 - 505.7)      927
                                                                                                                                                                                                                                                                                  
  T.Endocrine, metabolic and nutitional   413               1096.5 (941.4 - 1251.5)    1183        2268.6 (2018.8 - 2518.3)   1596            1770.2 (1556.5 - 1983.8)   712     1476.0 (1124.8 - 1827.3)   1750    2525.0 (2214.5 - 2834.5)   2462    2080.4 (1696.6 - 2464.2)   4058
                                                                                                                                                                                                                                                                                  
   Lipid disorder                         233               620.6 (520.3 - 720.9)      572         1092.5 (1005.7 - 1179.3)   805             892.9 (791.4 - 994.4)      358     723.9 (401.0 - 1046.8)     863     1223.8 (954.8 - 1492.8)    1221    1010.9 (698.7 - 1323.0)    2026
                                                                                                                                                                                                                                                                                  
   Diabetes                               137               362.6 (282.5 - 442.6)      474         925.3 (774.5 - 1076.0)     611             680.9 (587.1 - 774.6)      208     435.1 (354.1 - 516.1)      653     698.2 (938.8 - 997.6)      861     741.7 (678.9 - 804.4)      1472
                                                                                                                                                                                                                                                                                  
  U.Urology                               96                255.4 (165.0 - 345.8)      131         262.7 (152.0 - 373.4)      227             259.0 (158.2 - 359.8)      140     290.9 (220.6 - 361.1)      178     264.0 (218.4 - 309.7)      318     276.2 (220.0 - 332.5)      545
                                                                                                                                                                                                                                                                                  
  X.Genital Female                        \-                \-                         \-          \-                         \-              \-                         122     261.2 (196.0 - 326.4)      124     179.8 (153.3 - 206.3)      246     217.4 (180.6 - 254.3)      246
                                                                                                                                                                                                                                                                                  
  Y.Genital male                          50                140.3 (96.8 - 183.7)       252         470.4 (373.1 - 567.8)      302             333.9 (254.0 - 413.8)      \-      \-                         \-      \-                         \-                                 302

CI: Confidence interval. Estimated prevalence corresponds to each gender and age group and is expressed per 10000 residents

Differences between age groups
------------------------------

Significant differences in the prevalence of the diseases between the young and the elderly were observed (Table [4](#T4){ref-type="table"}). Of great importance were the differences in the general diseases, the diseases of the skin and the respiratory diseases, which were more prevalent in younger patients. In contrast, circulatory disorders were more prevalent in the elderly. Surprisingly, psychological disorders had similar overall prevalence in both genders and in both age groups, whereas anxiety disorders were more prevalent in the younger.

The differences between genders in each age group were not very prominent. In younger patients, circulatory diseases had similar prevalence between males and females, whereas coronary heart disease was significantly more prevalent in males. The same pattern was observed in the elderly, but with a more blunted difference. Musculoskeletal diseases were more prevalent in females in both age groups; however, the difference in the elderly was more prominent. Interestingly, the prevalence of COPD was similar in the two genders of the younger group, whereas it was more prevalent in elderly males compared to females.

Discussion
==========

The results of the present study indicate that circulatory and metabolic diseases represent the most important causes of morbidity in the general population visiting primary health care centres, followed by endocrine, metabolic, musculoskeletal and respiratory diseases. Significant variations in the prevalence of diseases between genders and age groups were observed. Our results support the fact that in Greece there is an unmet need for the development of a recording system in primary health care, in order the pattern of diseases in specific areas and age groups to be identified and effective strategies for the prevention and management of individual patients to be implemented.

The primary health care facilities of the National Health System in Greece are located mainly in rural areas. However, recently the first urban primary health centre was introduced in the Greek health care system, and Mariolis et al. showed that there are variations between urban and rural primary health centres \[[@B13]\]. The primary health centres selected for this study correspond to a rural and semirural population, since there are no urban primary health care centres in Thessaly.

The distribution of the diseases estimated in this study is similar with worldwide data. Data from WHO indicate that cardiovascular disease and diabetes mellitus are important causes for morbidity and mortality worldwide \[[@B2]\] and cardiovascular diseases are the leading cause of death worldwide, especially in women. In low and middle income countries of Europe in the age group of 15-59 years old, two thirds of all deaths are associated with cardiovascular diseases, cancer and other non-communicable diseases \[[@B2]\]. It is estimated that the global cardiovascular deaths will increase to 11.8 million in 2030 \[[@B2]\]. Data from the present study are in accordance with these data, since the results of this study indicate that the diseases of the circulatory system are the most prevalent in all age groups, both in males and females.

Another important group of diseases of high prevalence in the Greek population are neuropsychiatric disorders. Mental disorders are an important source of lost years of healthy life among women 15 to 44 years old \[[@B2]\]. Moreover, neuropsychiatric disorders have been observed also in the 16.5% of a representative sample of South African adults \[[@B14]\]. Our data indicate that the prevalence of depression is higher in women compared to men, in accordance with previous studies.

Recent data from a Spanish population have shown that the prevalence of chronic health problems in general practice was higher in women and increased with age \[[@B7]\], a finding similar to the present study. Arterial hypertension was the most prevalent disease in the Spanish study \[[@B7]\], and this was also the case in two other studies from Italy and Sweden \[[@B15],[@B16]\]. It is important to be noticed that these studies were performed in primary care, since data from secondary and tertiary care are additionally needed for the correct estimation of the disease prevalence \[[@B16]\]. A previous study in a random nationwide sample of adult Greek population has also indicated that self-reported arterial hypertension represents a significant public health problem \[[@B17]\].

One important difference between the present and the Spanish study is that COPD is more prevalent in Spain compared to our sample of Greek population \[[@B7]\]. The prevalence of COPD depends on the smoking pattern of each country \[[@B18]\], despite the fact that there is an increasing number of studies showing high rates of COPD in non-smokers \[[@B19]\]. There is a high prevalence of smoking in urban areas of Greece \[[@B20]\], which is lower in rural areas \[[@B21]\]. The fact that smoking rates are lower in the rural areas recorded in the present study, in combination with the underdiagnosis of COPD in Greece \[[@B22]\] may account for this discrepancy.

Several regions worldwide present a totally different pattern of diseases compared to our findings. For example, data from African studies indicate that the major causes of death in sub Saharan regions were communicable, maternal and perinatal conditions \[[@B23]\]. Despite the fact that in these regions the pattern of morbidity and mortality is entirely different, a rise in non communicable diseases has been recently observed \[[@B14]\].

Epidemiologic data depend on the presence of recording systems. Several studies have emphasized the usefulness of electronic health records in physicians\' practice. The development of a new pan-Canadian network for primary health care has been recently announced \[[@B24]\]. However, there is not adequate adoption of these records, even in US hospitals \[[@B25]\], and the proportion of physicians that use them remains very low, even in primary care settings \[[@B3]\]. The absence of epidemiologic data on many chronic diseases in Greece renders the conduction of large epidemiologic studies in general population imperative, in order to design new strategies in primary care.

Despite the large number of participants, the present study presents several limitations. Firstly, due to geographic reasons, our sample may present significant differences compared to the general population. Data from Eurostat indicate that in Greece the proportion of the population aged \> 65 years old is 18.6% \[[@B26]\], whereas in this study patients ≥65 years old represent over 50% of our sample. On the other hand the selected primary health care centres correspond to rural and semirural areas, with possible differences in the distribution of the population compared to urban areas. However, it should be mentioned that our study population represents approximately 16% of the population of the area that corresponds to the health care centres involved. Another possible bias is that the participation in the study was voluntary after invitation. Although there are no data on the morbidity of the subjects that were not willing to participate, the large number of participants, as well as the large number and the random order of visits in each health centre may minimize this factor. The additional evaluation of the patients\' health records may have further diminished the inaccurate recording of chronic diseases.

Conclusions
===========

In conclusion, the burden of chronic diseases in Greece seems to be similar with the burden observed in Europe, and especially in the middle and high income countries. Arterial hypertension, diabetes mellitus, diseases of the circulatory system and depression seem to be the most prevalent diseases. The present study revealed great variations in the prevalence of the diseases between genders and age groups. Our data justify the urgent need for the development of electronic health records that may help in the design of new prevention strategies in primary health care.
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